Accession Number:

ADA242876

Title:

Novel Approaches for Targeting Antiviral Agents in the Treatment of Arena-, Bunya-, Flavi-, and Retroviral

Descriptive Note:

Annual rept. 13 Dec 88-1 Jun 90,

Corporate Author:

SOUTH CAROLINA UNIV COLUMBIA SCHOOL OF MEDICINE

Report Date:

1990-06-01

Pagination or Media Count:

87.0

Abstract:

Administration of multiple doses of Poly IC-LC, Riker-3M or CL 246878 every other day for ten days did not prolong activation of immune functions. In some cases this treatment actually suppressed immune functions. Nevertheless, administration of multiple doses of these drugs had no adverse effect on resistance to Banzi virus infection. Encapsulation of Poly IC in liposomes resulted in a formulation which was more effective than free drug in augmenting immune functions and resistance to virus challenge. Poly IC conjugated to dextran was superior to free Poly IC-LC in inducing interferon and stimulating the reticuloendothelial system. In addition, Poly IC-dextran conjugates did not have the apparent toxic effects on the reticuloendothelial system that were observed with comparable doses of Poly IC-LC. Type 2 dengue virus strain 16681 infects squirrel monkeys as evidenced by both viremia and induction of anti-dengue antibodies. This virus model provides an opportunity to evaluate the therapeutic potential of immunomodulating and antiviral agents in non human primates infected with an arbovirus.

Subject Categories:

  • Medicine and Medical Research
  • Microbiology
  • Pharmacology
  • Test Facilities, Equipment and Methods

Distribution Statement:

APPROVED FOR PUBLIC RELEASE